COVID-19 VACCINE STUDY: 214-550-0354 or 972-636-1822
Do you suffer from Atopic Dermatitis or Eczema?
You may qualify for a new clinical study.
Research Your Health has begun a study of an investigational drug for the treatment of Atopic Dermatitis/Eczema. The goal of the study is to evaluate the immune response to vaccinations for patients receiving study drug.
You may pre-qualify for the Atopic Dermatitis Vaccine Study if you:
Are 18-54 years old / Are 12 - 54 years old (Adolescents will enroll later in the study)
Have a diagnosis of Atopic Dermatitis/Eczema, and were diagnosed at least 2 years ago
Have Atopic Dermatitis/Eczema that covers at least 10% of your Body Surface Area (the size of your hand is 1%)
Have used another Eczema treatment or cream in the last 6 months that didn’t fully treat your Eczema
Are willing to receive two vaccinations during study participation
VOLUNTEERS WHO QUALIFY TO TAKE PART IN THE STUDY MAY RECEIVE COMPENSATION FOR STUDY-RELATED TRAVEL.
If you think you might like to participate in the Atopic Dermatitis Vaccine Study or would like more information, please enter your information so we can confirm if you may qualify and can contact you about the study. Keep in mind that participation is entirely voluntary. If you do decide to take part in the study, you are free to change your mind about participating at any time.
currently enrolling subjects for
PAID CLINICAL RESEARCH participation
RESEARCH YOUR HEALTH | JEFFREY ADELGLASS, M.D., F.A.C.S.
6020 W. Parker Road, Suite 305, Plano, Texas 75093
Pre-Screen for a Study Now-Call Us: 214-550-0354 or 972-636-1822 | ResearchYourHealth.com